Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28.7M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
25K
-
Shares change
-
-337K
-
Total reported value, excl. options
-
$4.23K
-
Value change
-
-$96.9K
-
Number of sells
-
-16
-
Price
-
$0.17
Significant Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q3 2025
17 filings reported holding BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share as of Q3 2025.
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25K shares
of 28.7M outstanding shares and own 0.09% of the company stock.
Largest 10 shareholders include IFP Advisors, Inc (25K shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), SPROTT INC. (0 shares), VANGUARD GROUP INC (0 shares), UBS Group AG (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), NORTHERN TRUST CORP (0 shares), STATE STREET CORP (0 shares), RAYMOND JAMES FINANCIAL INC (0 shares), and MORGAN STANLEY (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.